These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 15276574)
21. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review]. Tanaka F; Wada H Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708 [TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy for lung cancer. Ikhlaque N; Baumann MA N Engl J Med; 2004 Apr; 350(16):1681-3; author reply 1681-3. PubMed ID: 15084703 [No Abstract] [Full Text] [Related]
23. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions]. Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813 [TBL] [Abstract][Full Text] [Related]
24. The potential role of surgery after induction treatment. Grunenwald DH; Albain KS Semin Radiat Oncol; 2004 Oct; 14(4):335-9. PubMed ID: 15558509 [TBL] [Abstract][Full Text] [Related]
25. Stage IB nonsmall cell lung cancers: are they all the same? Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113 [TBL] [Abstract][Full Text] [Related]
26. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy. Granone P; Van Schil P; Cesario A J Thorac Cardiovasc Surg; 2007 Jan; 133(1):275-6; author reply 276-7. PubMed ID: 17198837 [No Abstract] [Full Text] [Related]
27. [Early stages of non small cell lung cancer (I. II. IIIA). What is the best therapeutic strategy?]. Riquet M; Berna P Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S36-16S42. PubMed ID: 17268334 [TBL] [Abstract][Full Text] [Related]
28. The contemporary role of radiation therapy in the management of lung cancer. Mehta MP Surg Oncol Clin N Am; 2000 Jul; 9(3):539-61, ix. PubMed ID: 10853141 [TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. Pisters KM; Le Chevalier T J Clin Oncol; 2005 May; 23(14):3270-8. PubMed ID: 15886314 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Cerfolio RJ; Bryant AS; Jones VL; Cerfolio RM Eur J Cardiothorac Surg; 2009 Apr; 35(4):718-23; discussion 723. PubMed ID: 19233668 [TBL] [Abstract][Full Text] [Related]
32. [Our experience with patients operated after neoadjuvant therapy]. Juhász M; Egri G; Váradi C; Mészáros Z; Keszler P Magy Seb; 2004 Dec; 57(6):332-5. PubMed ID: 15803876 [TBL] [Abstract][Full Text] [Related]
33. [The role of neoadjuvant therapy in the treatment of locally advanced, stage III non-small-cell lung cancer]. Balikó Z; Sárosi V Magy Onkol; 2005; 49(2):161-8. PubMed ID: 16249813 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect? Besse B; Le Chevalier T J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602 [No Abstract] [Full Text] [Related]
35. The prognostic value of residual mediastinal involvement following induction therapy and surgery for locally advanced non-small cell lung cancer. Margaritora S; Cesario A; Galetta D; Porziella V; Sterzi S; Piraino A; Granone P; Cardaci V Lung Cancer; 2004 Oct; 46(1):125-6; author reply 127-8. PubMed ID: 15364141 [No Abstract] [Full Text] [Related]